Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia
Author(s) -
Andrew T. Gloster,
HansUlrich Wïttchen,
Franziska Einsle,
Michael Höfler,
Thomas Lang,
Sylvia HelbigLang,
Thomas Fydrich,
Lydia Fehm,
A Hamm,
Jan Richter,
Georg W. Alpers,
Alexander L. Gerlach,
A. Ströhle,
Tilo Kircher,
J. Deckert,
Peter Zwanzger,
Volker Arolt
Publication year - 2009
Publication title -
european archives of psychiatry and clinical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 98
eISSN - 1433-8491
pISSN - 0940-1334
DOI - 10.1007/s00406-009-0065-6
Subject(s) - agoraphobia , panic disorder , randomized controlled trial , psychology , cognitive behavioral therapy , psychotherapist , psychopathology , panic , mechanism (biology) , clinical psychology , cognition , medicine , psychiatry , anxiety , philosophy , epistemology
Cognitive behavioral therapy (CBT) is efficacious for panic disorder with agoraphobia (PD/A). Nevertheless, the active ingredients of treatment and the mechanisms through which CBT achieves its effects remain largely unknown. The mechanisms of action in CBT (MAC) study was established to investigate these questions in 369 patients diagnosed with PD/A. The MAC study utilized a multi-center, randomized controlled design, with two active treatment conditions in which the administration of exposure was varied, and a wait-list control group. The special feature of MAC is the way in which imbedded experimental, psychophysiological, and neurobiological paradigms were included to elucidate therapeutic and psychopathological processes. This paper describes the aims and goals of the MAC study and the methods utilized to achieve them. All aspects of the research design (e.g., assessments, treatment, experimental procedures) were implemented so as to facilitate the detection of active therapeutic components, and the mediators and moderators of therapeutic change. To this end, clinical, behavioral, physiological, experimental, and genetic data were collected and will be integrated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom